Top Markets
Coin of the day
Wuhan YZY Biopharma Co Ltd Wuhan YZY Biopharma Co Ltd

Wuhan YZY Biopharma Co Ltd

2496
Rang in Aktien #22213
Wuhan YZY Biopharma Co., Ltd. is a biotechnology enterprise specializing in the... Wuhan YZY Biopharma Co., Ltd. is a biotechnology enterprise specializing in the development of bispecific antibody-based treatments. Its therapeutic focus areas include various cancers, their associated complications, and age-related ophthalmic conditions. The company's extensive portfolio of drug candidates aims to address a wide range of diseases, such as malignant ascites, malignant pleural effusion, various solid tumors (including pancreatic cancer, hepatocellular carcinoma, other advanced solid tumors, and HER2-positive solid tumors), small cell lung cancer, and relapsed/refractory multiple myeloma. Additionally, they are advancing therapies for COVID-19 and several eye disorders like wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and other conditions characterized by abnormal blood vessel formation in the eye. The company, established in 2010, is headquartered in Wuhan, China.
Aktienkurs
$0.46053443
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$92.44M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-36.86%
Land
CN
Handel Wuhan YZY Biopharma Co Ltd (2496)

Kategorie

Dividendenhistorie für Wuhan YZY Biopharma Co Ltd (2496)
Wuhan YZY Biopharma Co Ltd (Aktienkürzel: 2496) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Wuhan YZY Biopharma Co Ltd (2496) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
0.00%
US
0.00%
NL
0.00%
US
64.00%
AU
0.00%
CH